Pancreatic enzyme replacement therapy after gastric resection: An update
Copyright policy )Pancreatic enzyme replacement therapy after gastric resection: An update
Exocrine pancreatic insufficiency (EPI) is one of the possible mechanisms of fat maldigestion following gastric surgery, together with reduced food intake, loss of gastric reservoir, small bowel bacterial overgrowth and rapid small bowel transit. Oral pancreatic enzyme replacement therapy (PERT) is the mainstay of treatment for EPI. The efficacy and safety of pancreatic enzyme substitution in patients following gastric resection remains unclear. This review article summarizes relevant studies addressing PERT after gastric resection.
Gastrointestinal Agents, Gastrectomy, Humans, Enzyme Replacement Therapy, Exocrine Pancreatic Insufficiency, Pancreas, Randomized Controlled Trials as Topic
Gastrointestinal Agents, Gastrectomy, Humans, Enzyme Replacement Therapy, Exocrine Pancreatic Insufficiency, Pancreas, Randomized Controlled Trials as Topic
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).24 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!